Rockefeller Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,666
| Closed | -$3K | – | 2521 |
|
|
2022
Q4 | $3K | Hold |
1,666
| – | – | ﹤0.01% | 3453 |
|
|
2022
Q3 | $4K | Hold |
1,666
| – | – | ﹤0.01% | 3391 |
|
|
2022
Q2 | $4K | Hold |
1,666
| – | – | ﹤0.01% | 3535 |
|
|
2022
Q1 | $6K | Hold |
1,666
| – | – | ﹤0.01% | 3270 |
|
|
2021
Q4 | $7K | Hold |
1,666
| – | – | ﹤0.01% | 3135 |
|
|
2021
Q3 | $10K | Hold |
1,666
| – | – | ﹤0.01% | 2885 |
|
|
2021
Q2 | $13K | Hold |
1,666
| – | – | ﹤0.01% | 2662 |
|
|
2021
Q1 | $17K | Hold |
1,666
| – | – | ﹤0.01% | 2345 |
|
|
2020
Q4 | $25K | Sell |
1,666
-1
| -0.1% | -$15 | ﹤0.01% | 1912 |
|
|
2020
Q3 | $28K | Hold |
1,667
| – | – | ﹤0.01% | 1675 |
|
|
2020
Q2 | $14K | Hold |
1,667
| – | – | ﹤0.01% | 1785 |
|
|
2020
Q1 | $12K | Buy |
+1,667
| New | +$12K | ﹤0.01% | 1678 |
|